Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- Author
- VALLE, Juan1 ; WASAN, Harpreet2 ; ROUGHTON, Michael4 ; BRIDGEWATER, John6 ; PALMER, Daniel H7 ; CUNNINGHAM, David3 ; ANTHONEY, Alan8 ; MARAVEYAS, Anthony9 ; MADHUSUDAN, Srinivasan10 ; IVESON, Tim11 ; HUGHES, Sharon4 ; PEREIRA, Stephen P5
[1] Christie Hospital, Manchester, United Kingdom
[2] Hammersmith Hospital, Imperial College Health Care Trust, United Kingdom
[3] Royal Marsden Hospital, United Kingdom
[4] Cancer Research United Kingdom and University College London CancerTrials Centre, United Kingdom
[5] Institute of Hepatology, University College London, United Kingdom
[6] University College London Cancer Institute, London, United Kingdom
[7] University Hospital Birmingham, Birmingham, United Kingdom
[8] St. James's Hospital, Leeds, United Kingdom
[9] Castle Hill Hospital, Hull, United Kingdom
[10] Nottingham University Hospitals, Nottingham, United Kingdom
[11] Southampton University Hospitals, Southampton, United Kingdom
ABC-02 Trial Investigators - Source
The New England journal of medicine. 2010, Vol 362, Num 14, pp 1273-1281, 9 p ; ref : 22 ref
- CODEN
- NEJMAG
- ISSN
- 0028-4793
- Scientific domain
- General medicine general surgery
- Publisher
- Massachusetts Medical Society, Waltham, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Association médicamenteuse Cancer des voies biliaires Cisplatine Etude comparative Gemcitabine Médecine Agent alkylant Antimétabolite Dérivé de la pyrimidine Fluor Composé organique Pathologie de l'appareil digestif Pathologie des voies biliaires Platine II Complexe Pyrimidine nucléoside
- Keyword (en)
- Antineoplastic agent Drug combination Bile duct cancer Cisplatin Comparative study Gemcitabine Medicine Alkylating agent Antimetabolic Pyrimidine derivatives Fluorine Organic compounds Digestive diseases Biliary tract disease Platinum II Complexes Pyrimidine nucleoside
- Keyword (es)
- Anticanceroso Asociación medicamentosa Cáncer de la vía biliar Cisplatino Estudio comparativo Gemcitabina Medicina Agente alquilante Antimetabólito Pirimidina derivado Fluor Compuesto orgánico Aparato digestivo patología Vía biliar patología Platino II Complejo Pirimidina nucleósido
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13C Liver. Biliary tract. Portal circulation. Exocrine pancreas / 002B13C01 Tumors
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen Generalities in medical sciences
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 22637520
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1056/NEJMoa0908721 
https://dx.doi.org/10.1056/NEJMoa0908721
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0908721\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:70:\"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"362\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1273\";s:8:\"\u0000*\u0000epage\";s:4:\"1281\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VALLE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Juan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"WASAN, Harpreet\";i:1;s:17:\"ROUGHTON, Michael\";i:2;s:17:\"BRIDGEWATER, John\";i:3;s:16:\"PALMER, Daniel H\";i:4;s:17:\"CUNNINGHAM, David\";i:5;s:14:\"ANTHONEY, Alan\";i:6;s:18:\"MARAVEYAS, Anthony\";i:7;s:22:\"MADHUSUDAN, Srinivasan\";i:8;s:11:\"IVESON, Tim\";i:9;s:14:\"HUGHES, Sharon\";i:10;s:18:\"PEREIRA, Stephen P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:70:\"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0908721\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:70:\"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"362\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1273\";s:8:\"\u0000*\u0000epage\";s:4:\"1281\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VALLE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Juan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"WASAN, Harpreet\";i:1;s:17:\"ROUGHTON, Michael\";i:2;s:17:\"BRIDGEWATER, John\";i:3;s:16:\"PALMER, Daniel H\";i:4;s:17:\"CUNNINGHAM, David\";i:5;s:14:\"ANTHONEY, Alan\";i:6;s:18:\"MARAVEYAS, Anthony\";i:7;s:22:\"MADHUSUDAN, Srinivasan\";i:8;s:11:\"IVESON, Tim\";i:9;s:14:\"HUGHES, Sharon\";i:10;s:18:\"PEREIRA, Stephen P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:70:\"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0908721\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0908721\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:70:\"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"362\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1273\";s:8:\"\u0000*\u0000epage\";s:4:\"1281\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VALLE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Juan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"WASAN, Harpreet\";i:1;s:17:\"ROUGHTON, Michael\";i:2;s:17:\"BRIDGEWATER, John\";i:3;s:16:\"PALMER, Daniel H\";i:4;s:17:\"CUNNINGHAM, David\";i:5;s:14:\"ANTHONEY, Alan\";i:6;s:18:\"MARAVEYAS, Anthony\";i:7;s:22:\"MADHUSUDAN, Srinivasan\";i:8;s:11:\"IVESON, Tim\";i:9;s:14:\"HUGHES, Sharon\";i:10;s:18:\"PEREIRA, Stephen P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:70:\"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0908721\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:70:\"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"362\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1273\";s:8:\"\u0000*\u0000epage\";s:4:\"1281\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VALLE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Juan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"WASAN, Harpreet\";i:1;s:17:\"ROUGHTON, Michael\";i:2;s:17:\"BRIDGEWATER, John\";i:3;s:16:\"PALMER, Daniel H\";i:4;s:17:\"CUNNINGHAM, David\";i:5;s:14:\"ANTHONEY, Alan\";i:6;s:18:\"MARAVEYAS, Anthony\";i:7;s:22:\"MADHUSUDAN, Srinivasan\";i:8;s:11:\"IVESON, Tim\";i:9;s:14:\"HUGHES, Sharon\";i:10;s:18:\"PEREIRA, Stephen P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:70:\"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1056\/NEJMoa0908721\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:70:\"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer\";s:9:\"\u0000*\u0000jtitle\";s:35:\"The New England journal of medicine\";s:9:\"\u0000*\u0000stitle\";s:15:\"N. Engl. j. med\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:3:\"362\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1273\";s:8:\"\u0000*\u0000epage\";s:4:\"1281\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0028-4793\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"VALLE\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Juan\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:15:\"WASAN, Harpreet\";i:1;s:17:\"ROUGHTON, Michael\";i:2;s:17:\"BRIDGEWATER, John\";i:3;s:16:\"PALMER, Daniel H\";i:4;s:17:\"CUNNINGHAM, David\";i:5;s:14:\"ANTHONEY, Alan\";i:6;s:18:\"MARAVEYAS, Anthony\";i:7;s:22:\"MADHUSUDAN, Srinivasan\";i:8;s:11:\"IVESON, Tim\";i:9;s:14:\"HUGHES, Sharon\";i:10;s:18:\"PEREIRA, Stephen P\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NEJMAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:70:\"Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer\";s:8:\"\u0000*\u0000place\";s:11:\"Waltham, MA\";s:6:\"\u0000*\u0000pub\";s:29:\"Massachusetts Medical Society\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
